James Vane
Stock Analyst at Jefferies
(0.62)
# 3,921
Out of 4,408 analysts
473
Total ratings
47%
Success rate
-2.1%
Average return
Main Sectors:
Stocks Rated by James Vane
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGEDF Gedeon Richter PLC | Maintained: Buy | $46 → $49 | $38.60 | +26.42% | 7 | Jun 12, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Hold | CHF 110.00 | $120.22 | -8.50% | 4 | Jun 11, 2026 | |
| LON: OXB Oxford Biomedica plc | Reiterated: Buy | 827p | $604.00 | +36.92% | 4 | Jun 2, 2026 | |
| ETR: MRK Merck KGaA | Initiated Coverage: Hold | €129.00 | $132.70 | -2.79% | 1 | May 26, 2026 | |
| BME: ROVI Laboratorios Farmaceuticos Rovi, S.A. | Maintained: Hold | €83.50 → €64.20 | $58.45 | +9.84% | 9 | May 13, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 769.00 → CHF 762.00 | $495.00 | +53.94% | 12 | May 13, 2026 | |
| SWX: SFZN Siegfried Holding AG | Maintained: Hold | CHF 94.50 → CHF 88.00 | $72.40 | +21.55% | 3 | May 13, 2026 | |
| ETR: SHL Siemens Healthineers AG | Maintained: Buy | €49.00 → €60.00 | $34.96 | +71.62% | 24 | May 7, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Maintained: Buy | €57.00 → €55.00 | $38.85 | +41.57% | 80 | May 6, 2026 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,360p → 1,870p | $1,467.00 | +27.47% | 27 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €32.00 → €31.00 | $40.70 | -23.83% | 90 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 75.00 → CHF 84.00 | $67.02 | +25.34% | 5 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €307.00 | $229.00 | +34.06% | 34 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | zł 204.00 → zł 188.00 | $175.70 | +7.00% | 3 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €210.00 → €246.00 | $181.20 | +35.76% | 2 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €229.00 → €262.00 | $175.40 | +49.37% | 13 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €15.50 | $17.34 | -10.61% | 8 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €34.10 | $24.98 | +36.51% | 40 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $23.08 | - | 24 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,250p → 1,420p | $1,215.00 | +16.87% | 15 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €333.00 → €368.00 | $340.50 | +8.08% | 12 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | CHF 49.30 | $66.60 | -25.98% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 260p → 298p | $216.50 | +37.64% | 17 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €49.00 → €61.50 | $50.65 | +21.42% | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $17 → $18 | $23.45 | n/a | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9.3 → $11 | $11.27 | n/a | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €4.49 | $4.04 | n/a | 7 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 147.00 → CHF 148.00 | $94.00 | n/a | 4 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 300p | $204.00 | n/a | 1 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 630.00 → kr 1,150 | $381.11 | n/a | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €135.00 → €43.00 | $13.73 | n/a | 2 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €28.70 | $68.75 | n/a | 1 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $16.75 | n/a | 2 | Jan 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.71 | n/a | 1 | Dec 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 93.00 | $212.50 | n/a | 1 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $31 | $13.33 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $40.51 | n/a | 1 | Aug 21, 2017 |
Gedeon Richter PLC
Jun 12, 2026
Maintained: Buy
Price Target: $46 → $49
Current: $38.60
Upside: +26.42%
Novartis AG
Jun 11, 2026
Maintained: Hold
Price Target: CHF 110.00
Current: $120.22
Upside: -8.50%
Oxford Biomedica plc
Jun 2, 2026
Reiterated: Buy
Price Target: 827p
Current: $604.00
Upside: +36.92%
Merck KGaA
May 26, 2026
Initiated Coverage: Hold
Price Target: €129.00
Current: $132.70
Upside: -2.79%
Laboratorios Farmaceuticos Rovi, S.A.
May 13, 2026
Maintained: Hold
Price Target: €83.50 → €64.20
Current: $58.45
Upside: +9.84%
Lonza Group AG
May 13, 2026
Maintained: Buy
Price Target: CHF 769.00 → CHF 762.00
Current: $495.00
Upside: +53.94%
Siegfried Holding AG
May 13, 2026
Maintained: Hold
Price Target: CHF 94.50 → CHF 88.00
Current: $72.40
Upside: +21.55%
Siemens Healthineers AG
May 7, 2026
Maintained: Buy
Price Target: €49.00 → €60.00
Current: $34.96
Upside: +71.62%
Fresenius SE & Co. KGaA
May 6, 2026
Maintained: Buy
Price Target: €57.00 → €55.00
Current: $38.85
Upside: +41.57%
Hikma Pharmaceuticals PLC
May 5, 2026
Reiterated: Buy
Price Target: 2,360p → 1,870p
Current: $1,467.00
Upside: +27.47%
May 5, 2026
Maintained: Sell
Price Target: €32.00 → €31.00
Current: $40.70
Upside: -23.83%
May 5, 2026
Maintained: Buy
Price Target: CHF 75.00 → CHF 84.00
Current: $67.02
Upside: +25.34%
Apr 23, 2026
Maintained: Buy
Price Target: €307.00
Current: $229.00
Upside: +34.06%
Apr 21, 2026
Maintained: Hold
Price Target: zł 204.00 → zł 188.00
Current: $175.70
Upside: +7.00%
Mar 18, 2026
Maintained: Buy
Price Target: €210.00 → €246.00
Current: $181.20
Upside: +35.76%
Mar 17, 2026
Maintained: Buy
Price Target: €229.00 → €262.00
Current: $175.40
Upside: +49.37%
Feb 11, 2026
Maintained: Hold
Price Target: €15.50
Current: $17.34
Upside: -10.61%
Feb 2, 2026
Maintained: Buy
Price Target: €34.10
Current: $24.98
Upside: +36.51%
Jan 16, 2026
Maintained: Hold
Price Target: n/a
Current: $23.08
Upside: -
Oct 29, 2025
Maintained: Hold
Price Target: 1,250p → 1,420p
Current: $1,215.00
Upside: +16.87%
Oct 22, 2025
Maintained: Hold
Price Target: €333.00 → €368.00
Current: $340.50
Upside: +8.08%
Sep 25, 2025
Initiated Coverage: Sell
Price Target: CHF 49.30
Current: $66.60
Upside: -25.98%
Aug 15, 2025
Maintained: Buy
Price Target: 260p → 298p
Current: $216.50
Upside: +37.64%
Aug 11, 2025
Upgraded: Buy
Price Target: €49.00 → €61.50
Current: $50.65
Upside: +21.42%
Aug 8, 2024
Maintained: Sell
Price Target: $17 → $18
Current: $23.45
Upside: n/a
May 14, 2024
Maintained: Buy
Price Target: $9.3 → $11
Current: $11.27
Upside: n/a
Jan 5, 2024
Maintained: Hold
Price Target: €4.49
Current: $4.04
Upside: n/a
Feb 23, 2023
Maintained: Buy
Price Target: CHF 147.00 → CHF 148.00
Current: $94.00
Upside: n/a
Nov 22, 2022
Initiated Coverage: Buy
Price Target: 300p
Current: $204.00
Upside: n/a
Feb 8, 2022
Initiated Coverage: Buy
Price Target: kr 630.00 → kr 1,150
Current: $381.11
Upside: n/a
Jan 28, 2022
Downgraded: Hold
Price Target: €135.00 → €43.00
Current: $13.73
Upside: n/a
Aug 27, 2021
Maintained: Sell
Price Target: €28.70
Current: $68.75
Upside: n/a
Jan 20, 2020
Downgraded: Sell
Price Target: n/a
Current: $16.75
Upside: n/a
Dec 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $8.71
Upside: n/a
Nov 1, 2018
Maintained: Buy
Price Target: kr 93.00
Current: $212.50
Upside: n/a
Nov 1, 2017
Maintained: Sell
Price Target: $31
Current: $13.33
Upside: n/a
Aug 21, 2017
Upgraded: Hold
Price Target: n/a
Current: $40.51
Upside: n/a